Adjuvant and immunostimulatory effects of a D-galactose-binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis
© Cardoso et al.; licensee BioMed Central Ltd. 2012
Received: 31 May 2012
Accepted: 10 October 2012
Published: 29 October 2012
Vaccination is an important control measure for neosporosis that is caused by a coccidian parasite, Neospora caninum, leading to abortion and reproductive disorders in cattle and serious economic impacts worldwide. A D-galactose-binding lectin from Synadenium carinatum latex (ScLL) was recently described by our group with potential immunostimulatory and adjuvant effects in the leishmaniasis model. In this study, we evaluated the adjuvant effect of ScLL in immunization of mice against neosporosis. First, we investigated in vitro cytokine production by dendritic cells stimulated with Neospora lysate antigen (NLA), ScLL or both. Each treatment induced TNF-α, IL-6, IL-10 and IL-12 production in a dose-dependent manner, with synergistic effect of NLA plus ScLL. Next, four groups of C57BL/6 mice were immunized with NLA + ScLL, NLA, ScLL or PBS. The kinetics of antibody response showed a predominance of IgG and IgG1 for NLA + ScLL group, whereas IgG2a response was similar between NLA + ScLL and NLA groups. Ex vivo cytokine production by mouse spleen cells showed the highest IFN-γ/IL-10 ratio in the presence of NLA stimulation for mice immunized with NLA + ScLL and the lowest for those immunized with ScLL alone. After parasite challenge, mice immunized with NLA + ScLL or ScLL alone presented higher survival rates (70-80%) and lower brain parasite burden as compared to PBS group, but with no significant changes in morbidity and inflammation scores. In conclusion, ScLL combined with NLA was able to change the cytokine profile induced by the antigen or lectin alone for a Th1-biased immune response, resulting in high protection of mice challenged with the parasite, but with low degree of inflammation. Both features may be important to prevent congenital neosporosis, since protection and low inflammatory response are necessary events to guide towards a successful pregnancy.
KeywordsNeospora caninum Vaccination Adjuvant Plant lectin
Neospora caninum is a coccidian parasite, closely related to Toxoplasma gondii, with broad host range and worldwide distribution, causing neuromuscular disease in dogs and abortion or reproductive disorders in cattle . Neosporosis seriously impacts the dairy and beef industries leading to substantial economic losses . Cattle acquire the infection by horizontal transmission, through ingestion of food and drinking water contaminated with oocysts, which are excreted in faeces of canine definitive hosts [3–5]; or more often, by transplacental vertical transmission, endogenous or exogenous, from an infected dam to her offspring during pregnancy . Hence, tachyzoites can cross the placenta and infect the foetus, causing abortion or congenital infection, depending on the gestational age .
Humoral and cell-mediated immune responses are observed in experimentally and naturally infected cattle . A Th1-type immune response characterized by increased production of IFN-γ, IL-12, and IgG2a isotype is usually protective against acute N. caninum infection in murine models . However, this type of response may interfere with a successful pregnancy and lead to abortion if the infection occurs in early pregnancy . On the other hand, a successful pregnancy depends on a switch to a Th2-type immune response at the maternal-fetal interface, in order to allow the acceptance of the fetal allograft . In addition, innate immune response is also involved in host defense against N. caninum infection, mostly by means of Toll-like receptors (TLRs), such as TLR2 that participates in the induction of Th1-biased immune responses against this parasite .
Several control measures have been investigated to prevent N. caninum transmission and infection . Numerous attempts to develop vaccines based on single or multiple recombinant proteins [12–15], proteins expressed from a vector system [16, 17], γ-irradiated tachyzoites , attenuated tachyzoites , and different combinations of antigens and adjuvants [20–23], have been tested, but not yet with great success. All these vaccination strategies have shown that protection is sometimes partial and depends on the type of antigen as well as the adjuvant used.
Lectins are proteins that bind specifically to carbohydrates  and are isolated from different sources in nature. Plant lectins with increasing biological interest have been isolated from the Moraceae family, such as Jacalin and ArtinM from seeds of jackfruit (Artocarpus integrifolia), and have been widely described for its immunostimulatory potential as observed by robust cell proliferation and cytokine production [25–27]. A D-galactose-binding lectin named Synadenium carinatum latex lectin (ScLL) from the Euphorbiaceae family was recently described by our group  and its immunostimulatory and adjuvant effects have been determined in an experimental model of cutaneous leishmaniasis . It was observed that ScLL associated or not with the soluble antigen from Leishmania amazonensis induced a potent Th1-biased immune response characterized by production of IL-12, IFN-γ, TNF-α mRNAs and specific IgG2a isotype, resulting in reduced infection rates after challenge with L. amazonensis. In a model of asthma to study the effects of this lectin, it was observed that oral administration of ScLL inhibited neutrophil and eosinophil extravasations during acute and chronic inflammation, and reduced eosinophil and mononuclear blood counts during chronic asthma, showing an immunoregulatory effect .
Considering these relevant biological effects so far described for ScLL, the major aim of the present study was to evaluate if this lectin could exert any immunostimulatory and protective roles as adjuvant in an immunization protocol of mice for Neospora caninum infection.
Materials and methods
Parasite and antigen
Neospora caninum tachyzoites (Nc-1 isolate)  were maintained by serial passages in Vero cell line cultured in RPMI 1640 medium supplemented with 2% heat-inactivated calf fetal serum (CFS), 2 mM glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin at 37°C in 5% CO2 atmosphere. Parasite suspensions were obtained as previously described . Briefly, tachyzoites were harvested by scraping off the cell monolayer after 2–3 days of infection, passed through a 26-gauge needle and centrifuged at low speed (45 × g) for 1 min at 4°C. The supernatant containing parasite suspension was collected, washed in phosphate buffered saline (PBS, pH 7.2), and the pellet was resuspended in PBS for antigen preparation or the tachyzoites were immediately used for animal challenge.
Neospora lysate antigen (NLA) was prepared as previously described . Briefly, parasite suspension was treated with protease inhibitors and then lysed by freeze-thaw cycles followed by ultrasound on ice. After centrifugation (10,000 × g, 30 min, 4°C), the supernatant was collected, filtered on 0.22 μm membranes and its protein concentration determined by bicinchoninic acid (BCA) assay . NLA aliquots were stored at −20°C until using in immunization procedures, serological assays and in vitro and ex vivo cytokine production assays.
Lectin from Synadenium carinatum latex (ScLL)
Synadenium carinatum specimens were harvested in Uberlândia, MG, Brazil, and registered in the Herbarium of the Federal University of Uberlândia (HUFU no. 84 38354). ScLL was obtained as previously described , with some modifications. Briefly, proteins were extracted from the fresh plant latex by gentle shaking with distilled water, at 1:10 proportion, for 48 h at 4°C. The mixture was centrifuged (3500 × g, 30 min, 4°C) and the supernatant was filtered on 0.45 μm membranes, consisting in the total aqueous extract. Next, the total extract was submitted to affinity chromatography using immobilized D-galactose column on agarose (Pierce, Rockford, IL), equilibrated with 5 mM borate-buffered saline, pH 8.0 (BBS). The D-galactose-binding lectin (ScLL) was eluted with 0.4 M D-galactose (Sigma Chemical Co., St Louis, MO) in BBS, dialyzed against deionized water and the protein concentration was determined by BCA assay . Hemagglutination assays were performed to confirm the lectin activity of ScLL as previously described . ScLL aliquots were stored at −20°C until using in immunization procedures and in vitro cytokine production assays.
Female C57BL/6 mice with 8–12 weeks old were obtained from the School of Medicine of Ribeirão Preto (FMRP), University of São Paulo (USP), Ribeirão Preto, SP, Brazil. Animals were maintained under standard conditions in the Animal Facility from Federal University of Uberlândia (UFU), Uberlândia, MG, Brazil. All procedures were conducted according to guidelines for animal ethics and the study received approval of the Ethics Committee for Animal Experimentation of the Institution.
In vitro cytokine production assays
Naive C57BL/6 mice (n=3) were euthanized, their thigh-bone and shin-bone were removed and bone marrow cells were aseptically collected for cell culture. Bone marrow cells were differentiated in dendritic cells as previously described , by treating cells with 30 ng/mL of granulocyte-macrophage colony-stimulating factor (GM-CSF) in RPMI medium supplemented with 20% CFS for 7 days. Afterward, cells were washed with RPMI medium containing 10% CFS continuously in an ice bath for removal of differentiated dendritic cells. Cell suspensions were washed (400 × g, 10 min, 4°C) and the pellet was resuspended in RPMI medium containing 10% CFS. Viable cells were counted in a hemocytometer, using the Trypan blue exclusion vital stain, with more than 90% cell viability.
Dendritic cell suspensions (2 × 105 cells/200 μL/well) were cultured in triplicate in 96-well culture plates and stimulated with NLA at different concentrations (25, 10, 5, and 1 μg/mL), or ScLL (10, 1, 0.1, and 0.01 μg/mL) in RPMI medium with 10% CFS. In further experiments, cells were stimulated with NLA at 25 μg/mL plus ScLL at different concentrations (10, 1, 0.1, and 0.01 μg/mL), since the highest concentration of NLA showed to have better stimulatory effect. Cells stimulated with medium alone or LPS (10 μg/mL) were included as controls. Cells were incubated for 48 h at 37°C in 5% CO2. Cell supernatants were then collected, centrifuged (3000 × g, 5 min, 4°C) and stored at −70°C for the detection of TNF-α, IL-6, IL-10 and IL-12p40. Cytokine measurements were performed by sandwich ELISAs according to manufacturer’s instructions (R&D Systems, Minneapolis, MN). The limit of detection was 31 pg/mL for all cytokines.
Four groups of 13 mice were immunized subcutaneously three times at two-week intervals, with 200 μL/animal of the following formulations: 25 μg of NLA plus 50 μg of ScLL in sterile PBS (NLA + ScLL group); 25 μg of NLA alone (NLA group); 50 μg of ScLL alone (ScLL group); and PBS only. The adopted doses of antigen and lectins were based on previous studies [27, 29]. Blood samples were collected at 0, 15, 30, 45, 60 and 90 days after immunization (d.a.i.), and the sera were analyzed for the presence of specific antibodies. Two weeks after the last immunization (45 d.a.i.), three mice in each group were euthanized and their spleens were aseptically removed for cell culture and cytokine production assay.
Ex vivo cytokine production assays
Spleens were macerated in RPMI medium and cell suspensions were washed with medium, treated with lysis buffer (0.16 M NH4Cl and 0.17 M Tris–HCl, pH 7.5), washed again and resuspended in RPMI medium containing 10% CFS. Cells (2 × 105 cells/200 μL/well) were cultured in triplicate in 96-well culture plates in the presence of mitogen (Concanavalin A - ConA, 2.5 μg/mL), antigen (NLA, 10 μg/mL) or medium alone and incubated at 37°C in 5% CO2 atmosphere. After 48 h, the cell-free supernatants were collected and stored at −70°C for cytokine quantification. IL-10 and IFN-γ measurements were performed by sandwich ELISAs according to manufacturer’s instructions (R&D Systems, Minneapolis, MN). The limit of detection was 31 pg/mL for both cytokines.
Challenge of immunized mice
Four weeks after the last immunization (60 d.a.i.), ten animals per group were challenged intraperitoneally with 2×107 Nc-1 tachyzoites. Animals were observed daily for clinical signs, by evaluating morbidity scores, body weight changes and mortality. Morbidity scores were calculated as previously described , with modifications: sleek/glossy coat, bright and active (score 0); ruffled coat (score 1); hunched, tottering gait, starry stiff coat (score 2), reluctance to move (score 3). All surviving animals were euthanized at 30 days after challenge (90 d.a.i.), when brain tissues were collected, sliced longitudinally, being half stored at −70°C for quantification of parasite burden by real-time polymerase chain reaction (PCR) assay target “Nc-5”. The remaining tissue was fixed in 10% buffered formalin, embedded in paraffin and routinely processed for immunohistochemical and histological assays.
Determination of N. caninum-specific antibodies
Levels of N. caninum-specific total IgG, IgG1 and IgG2a antibodies were measured by ELISA as previously described [21, 27]. Briefly, high-binding microtiter plates were coated with NLA (0.5 μg/well) and blocked with 5% skim milk in PBS plus 0.05% Tween 20 (PBS-T). Serum samples were diluted 1:25 in 1% skim milk-PBS-T and incubated for 1 h (IgG) or 2 h (IgG1 and IgG2a) at 37°C. After washing, peroxidase-labeled goat anti-mouse IgG (1:1000; Sigma) or biotin-labeled goat anti-mouse IgG1 (1:4000) or anti-mouse IgG2a (1: 2000) antibodies (Caltag Lab. Inc., South San Francisco, CA) were added and incubated for 1 h at 37°C. Next, streptavidin-peroxidase (1:1000; Sigma) was added for IgG1 and IgG2a detection assays. The assays were developed with 0.01 M 2,2-azino-bis-3-ethyl-benzthiazoline sulfonic acid (ABTS; Sigma) and 0.03% H2O2. Optical density (OD) values were determined in a plate reader at 405 nm.
Determination of parasite burden in brain tissue
Parasite burden in the brain tissue from all surviving mice after 30 days of challenge was determined by quantitative real-time polymerase chain reaction (qPCR) as described elsewhere . The following typical Nc-5 primers (Np6/Np21) were used: sense (3’-GCTGAACACCGTATGTCGTAAA-5’) and antisense (3’-AGAGGAATGCCACATAGAAGC-5’) to detect the N. caninum Nc-5 sequence through SYBR green detection system (Invitrogen, San Francisco, CA). DNA extraction was performed from 20 mg of murine brain tissues using the Wizard SV Genomic DNA kit (Promega Co., Madison, WI) according to the manufacturer’s instructions. DNA concentrations were determined by UV spectrophotometry (260 nm) and adjusted to 200 ng/μL with sterile DNAse free water. Assays to determine N. caninum tachyzoite loads were performed through real-time PCR (7500 Real time PCR System, Applied Biosystems, Foster City, CA) and parasite burden was calculated by interpolation from a standard curve with DNA equivalents extracted from Nc-1 tachyzoites included in each run. Brain tissue from non-immunized and unchallenged mice was analyzed in parallel as negative control.
Immunohistochemical assays were also performed to verify brain tissue parasitism as previously described [21, 27]. Briefly, deparaffinized sections were blocked with 3% H2O2, treated with 0.2 M citrate buffer (pH 6.0) in microwave oven to rescue antigenic sites, and blocked with 2% non-immune goat serum. Next, primary antibody consisting of sera from mice experimentally infected with N. caninum was added followed by secondary biotinylated goat anti-mouse IgG antibody (Sigma) and avidin–biotin peroxidase complex (ABC kit, PK-4000; Vector Laboratories Inc., Burlingame, CA). The reaction was developed with 0.03% H2O2 plus 3,3Â´-diaminobenzidine tetrahydrochloride (DAB; Sigma) and slides were counterstained with Harris haematoxylin and examined under light microscopy.
Determination of inflammation scores in brain tissue
Brain tissue sections obtained from all surviving mice after 30 days of challenge were stained with haematoxylin and eosin, according to previously described protocol [21, 27], and then examined by microscopy to detect tissue damage. Inflammation scores were represented as arbitrary units: 0–1, mild; 1–2, moderate; 2–3, severe and > 3, very severe. Brain tissue from non-immunized and unchallenged mice served as negative controls.
Statistical analysis was carried out using GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA). Differences between groups were analyzed using ANOVA or Kruskal-Wallis test, when appropriate, with the respective Bonferroni or Dunn multiple comparison post-tests to examine all possible pairwise comparisons. Student t test was used for comparison between IgG1 and IgG2a isotypes in different groups. The Kaplan–Meier method was applied to estimate the percentage of mice surviving at each time point after challenge and survival curves were compared using the Log-rank test. Values of P < 0.05 were considered statistically significant.
In vitro cytokine production by dendritic cells stimulated with NLA and/or ScLL
Humoral immune response after immunization and parasite challenge
Seroconversion of control groups and comparison between IgG1 and IgG2a levels to N. caninum were analyzed before (60 d.a.i.) and after (90 d.a.i.) parasite challenge in all experimental groups (Figure 2D). Before challenge, all animals immunized with NLA alone or associated with ScLL presented higher levels of IgG1 than IgG2a (P < 0.05). After challenge, this predominant IgG1 pattern was maintained, although no significant increase in IgG1 levels was observed after challenge, except for the ScLL and PBS control groups, thus confirming their seroconversion. In contrast, IgG2a levels were significantly increased after challenge in all experimental groups, with similar levels between IgG1 and IgG2a only in the PBS group (Figure 2D).
Ex vivo cytokine production by spleen cells from mice after immunization
After mitogen stimulation, all groups showed cytokine production above the baseline (medium), markedly for IFN-γ in the groups NLA + ScLL, NLA and ScLL (Figure 3A), whereas IL-10 production was moderate and more evident in the group with ScLL alone (Figure 3B).
Mortality and parasite burden after challenge
Brain tissue inflammation after parasite challenge
Adjuvants play an important role in the efficacy of vaccines, contributing to increase the potency and kinetics of the immune response and to direct the type of this response. In the induction of immune responses, protein-carbohydrate interactions are essential since they represent cell-to-cell contacts, leading to crosstalk among cells and consequently their activation . Lectins can play this role given that it may bind carbohydrates and function as pattern recognition receptors (PRRs) in host cells . Several plant lectins have shown adjuvant or immunostimulatory effects in different infections [25, 27, 29, 37]. Among them, the lectin from the S. carinatum latex (ScLL) has been recently studied for its peculiar roles in different experimental models, having an adjuvant effect in cutaneous leishmaniasis  or immunoregulatory action in asthma murine models .
Given that currently there is no effective treatment for neosporosis, control methods are necessary. Among them, the removal of infected animals is the only way to reduce incidence of the disease in herds. However, given the high prevalence of N. caninum and the low occurrence of abortion in herds (less than 5% of cows abort), it does not make sense to cull infected animals. Usually animals are culled due to poor reproductive success, which Neospora infection may be one reason. Thus, vaccination may be a viable method of reducing the incidence of neosporosis and improving the reproductive performance in herds . In this context, several studies have been conducted to obtain reliable formulations in vaccination strategies in order to protect against N. caninum infection [38–40], but studies using plant lectins as adjuvants in neosporosis are scarce in the literature. Recently, we evaluated the role of lectins (ArtinM and Jacalin) from the jackfruit (Artocarpus integrifolia) and showed that ArtinM, a D-mannose binding lectin, presented stronger immunostimulatory and adjuvant effect than Jacalin, a D-galactose binding lectin, in immunization of mice against neosporosis, by inducing a protective Th1-biased pro-inflammatory immune response and higher protection after parasite challenge .
In the present study, we investigated if another D-galactose binding lectin, ScLL obtained from the Synadenium carinatum latex, could play immunostimulatory role and adjuvant effect in mouse immunization against N. caninum infection as already reported in other infection models. First, we evaluated the in vitro cytokine production by dendritic cells stimulated with antigen, lectin or by the combination of both. We found that NLA, ScLL or NLA + ScLL produced the highest levels of all cytokines investigated (TNF-α, IL-6, IL-10 and IL-12), showing a typical profile of a dose-dependent response, when tested in their greatest concentrations. Also, it was clearly evident the synergistic effect of NLA and ScLL, since cells stimulated with NLA + ScLL secreted the highest levels of all cytokines. These findings indicate that ScLL was able to increase the immunogenicity of the antigen, demonstrating its adjuvant role in the in vitro experiments. In addition, as dendritic cells are professional APCs and have critical functions in modulation of the primary immune response to intracellular parasites, this can be particularly important in vaccination strategies for N. caninum. In this context, the TLR2 innate immune receptor is decisive for dendritic cell activation during N. caninum infection, by using the TLR2/MyD88 recognition pathway with posterior expression of costimulatory and antigen-presentation molecules, T lymphocyte programming, and pro-inflammatory cytokine production, associated with an appropriate IgG synthesis against the parasite . Furthermore, ScLL itself has already shown to increase the expression of IL-12, IL-1 and TNF-α mRNAs in macrophages pretreated with the lectin (10 μg/mL) and infected with L. amazonensis.
The kinetics of the humoral immune response after immunization of mice with NLA, ScLL or both revealed a distinct profile between the IgG1 and IgG2a isotypes, with predominance of IgG1 in all time points analyzed for the NLA + ScLL group, thus reflecting its higher production of IgG in relation to other groups. Before parasite challenge (60 d.a.i.), the NLA group reached similar IgG1 levels to the NLA + ScLL group, but significantly higher than IgG2a levels, demonstrating that NLA alone is also able to induce a Th2-biased humoral immune response. After parasite challenge, there was no significant increase in the levels of IgG1 in NLA-immunized groups, even though they maintained higher than IgG2a in all experimental groups. Regarding the control groups, seroconversion was observed in response to challenge with predominance of the IgG1 isotype, particularly evident in the ScLL group, indicating that this lectin alone is able to direct a Th2-biased humoral immune response. In contrast, IgG2a levels increased after parasite challenge in all groups, and this may represent a shift from Th2-biased immune response to a more protective Th1-biased immune response. Our previous study also showed higher levels of IgG1 than IgG2a after challenge in all groups of mice immunized with NLA associated or not with lectins ArtinM or Jacalin, indicating that this Th2 type of humoral immune response seems to be dependent on the antigen rather than the adjuvant . Indeed, our previous study has shown a considerable increment in both antibody isotypes after challenge in NLA-immunized groups associated or not with CpG, suggesting that the parasite was able to induce both Th2 and Th1 immune responses, although a Th2-biased humoral response was more evident .
In order to observe the immunization-induced cytokine profile before parasite challenge, we evaluated the ex vivo cytokine production by spleen cells from mice immunized with NLA associated or not with ScLL. After antigenic stimulation, both NLA + ScLL and NLA groups showed similar and increased IFN-γ production, but a distinct pattern was found for IL-10, with increased cytokine production in the groups immunized with antigen or lectin alone. When the IFN-γ/IL-10 ratio was analyzed in an attempt to verify the balance between pro-inflammatory and anti-inflammatory cytokines, the highest ratio was found for the NLA + ScLL group and the lowest for the ScLL alone. These results suggest that the ScLL lectin alone is able to induce higher levels of IL-10, leading to an anti-inflammatory or regulatory immune response pattern. It is noteworthy that spleen cells from the ScLL group stimulated with mitogen also showed the highest IL-10 production. In our previous study  mice immunized with NLA alone also showed high IL-10 levels, reinforcing the role of the NLA antigen in inducing an anti-inflammatory or immunoregulatory response. In addition, mice immunized with NLA plus Jacalin or Jacalin alone exhibited the lowest ratio IFN-γ/IL-10 ratio whereas those immunized with NLA + ArtinM or ArtinM alone presented the highest ratio, suggesting that the lectin adjuvant, but not the antigen, was able to modulate the cytokine production, leading to a Th1 type-biased pro-inflammatory immune response [25, 27, 37].
In the present study, the combination of NLA plus ScLL was also able to change the cytokine profile induced by the antigen or lectin alone for a Th1-biased immune response, indicating a potential adjuvant effect. In our previous studies, however, the ScLL lectin has shown contrasting roles depending on the study model. In immunization of mice against L. amazonensis, ScLL induced increased levels of IgG2a and overexpression of IL-12 and TNF-α mRNAs, leading to a Th1-biased immune response that supported the protective function of this lectin against cutaneous leishmaniasis . Primed macrophages when treated with ScLL showed no significant nitrite oxide (NO) production after infection with L. amazonensis, although they were able to reduce parasite intracellular proliferation . Additionally, oral administration of ScLL reduced IL-4 and IL-5 levels in murine models of acute and chronic inflammation and lead to increased IFN-γ and IL-10 production in asthma inflammatory model, directing a shift from Th2- to Th1-biased immune response .
It is well known that a protective immune response against N. caninum should be a non-exacerbated Th1-type response . Accordingly, in a previous study we demonstrated that a strong cellular immune response associated with increased IFN-γ production and inflammation induced by vaccination with N. caninum excreted-secreted antigen (NcESA) alone or CpG-adjuvanted NcESA rendered mice more susceptible to parasite challenge . In the present study, mice immunized with NLA plus ScLL or ScLL alone presented the highest survival rate (70-80%) and the lowest brain parasite burden, with no significant differences in morbidity scores and body weight changes from baseline. Therefore, the ScLL lectin associated or not with NLA is able to confer protection against parasite challenge regardless of inflammation. Accordingly, a previous study suggests that ScLL inhibits IκBα degradation, a negative regulator of pro-inflammatory NF-κB . In our previous study, mice immunized with ArtinM combined with NLA presented a higher survival rate (86%), even though with high brain tissue inflammation scores, whereas animals immunized with Jacalin alone or associated with NLA had the lowest inflammation scores, but with intermediate survival rates (50–62%) . Therefore, the induction of a pro-inflammatory immune response by ArtinM plus NLA seems to be more favorable than detrimental to the host to control neosporosis. This has been reported for the control of leishmaniasis, where ArtinM plus soluble Leishmania antigen induced a potent pro-inflammatory response with reduction of the parasite load, but without decreasing the lesion size . In the present study, however, mice immunized with NLA alone presented a low survival rate associated with a high brain parasite burden, similarly to the PBS control group, suggesting that NLA alone stimulated a non-protective Th2-biased immune response .
Recent studies have shown that different administration routes and delivery strategies in vaccination against neosporosis in murine models may play a key role in directing the immune response towards a more protective pattern [39, 42, 43]. In this framework, innate responses are crucial for stimulating the Th1-type antibody-and cell-mediated immune responses and lectins play an important role in the protein-carbohydrate binding that mediates the parasite-host cell interactions.
Altogether, the results of the present study showed that ScLL, a D-galactose-binding lectin, when combined with NLA antigen can be used as powerful adjuvant in immunization procedures against neosporosis, resulting in high protection of mice challenged with the parasite, but with low degree of inflammation. In addition, the D-galactose-binding seems not be essential for these effects, since another D-galactose binding lectin, Jacalin, showed to be a poor adjuvant in immunization against neosporosis . Future studies should be conducted to evaluate if the immunostimulatory and adjuvant effects of the ScLL lectin may be important to prevent congenital neosporosis, since protection and low inflammatory response are necessary events to guide towards a successful pregnancy.
We thank Cristina R. Barros-Cardoso, PhD. due to the valuable suggestions for the elaboration of the manuscript. This study was supported by Brazilian Funding Agencies (CNPq, FAPEMIG, and CAPES).
- Dubey JP, Schares G, Ortega-Mora LM: Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev. 2007, 20: 323-367. 10.1128/CMR.00031-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Reichel MP, Ellis JT: Neospora caninum - how close are we to development of an efficacious vaccine that prevents abortion in cattle?. Int J Parasitol. 2009, 39: 1173-1187. 10.1016/j.ijpara.2009.05.007.View ArticlePubMedGoogle Scholar
- McAllister MM, Dubey JP, Lindsay DS, Jolley WR, Wills RA, McGuire AM: Dogs are definitive hosts of Neospora caninum. Int J Parasitol. 1998, 28: 1473-1478. 10.1016/S0020-7519(98)00138-6.View ArticlePubMedGoogle Scholar
- Gondim LF, McAllister MM, Pitt WC, Zemlicka DE: Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J Parasitol. 2004, 34: 159-161. 10.1016/j.ijpara.2004.01.001.View ArticlePubMedGoogle Scholar
- King JS, Slapeta J, Jenkins DJ, Al-Qassab SE, Ellis JT, Windsor PA: Australian dingoes are definitive hosts of Neospora caninum. Int J Parasitol. 2010, 40: 945-950. 10.1016/j.ijpara.2010.01.008.View ArticlePubMedGoogle Scholar
- Trees AJ, Williams DJ: Endogenous and exogenous transplacental infection in Neospora caninum and Toxoplasma gondii. Trends Parasitol. 2005, 21: 558-561. 10.1016/j.pt.2005.09.005.View ArticlePubMedGoogle Scholar
- Williams DJ, Guy CS, McGarry JW, Guy F, Tasker L, Smith RF, MacEachern K, Cripps PJ, Kelly DF, Trees AJ: Neospora caninum-associated abortion in cattle: the time of experimentally-induced parasitaemia during gestation determines foetal survival. Parasitology. 2000, 121: 347-358. 10.1017/S0031182099006587.View ArticlePubMedGoogle Scholar
- Andrianarivo AG, Anderson ML, Rowe JD, Gardner IA, Reynolds JP, Choromanski L, Conrad PA: Immune responses during pregnancy in heifers naturally infected with Neospora caninum with and without immunization. Parasitol Res. 2005, 96: 24-31. 10.1007/s00436-005-1313-y.View ArticlePubMedGoogle Scholar
- Baszler TV, Long MT, McElwain TF, Mathison BA: Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Int J Parasitol. 1999, 29: 1635-1646. 10.1016/S0020-7519(99)00141-1.View ArticlePubMedGoogle Scholar
- Innes EA, Wright S, Bartley P, Maley S, Macaldowie C, Esteban-Redondo I, Buxton D: The host-parasite relationship in bovine neosporosis. Vet Immunol Immunopathol. 2005, 108: 29-36. 10.1016/j.vetimm.2005.07.004.View ArticlePubMedGoogle Scholar
- Mineo TWP, Oliveira CJ, Gutierrez FR, Silva JS: Recognition by Toll-like receptor 2 induces antigen-presenting cell activation and Th1 programming during infection by Neospora caninum. Immunol Cell Biol. 2010, 88: 825-833. 10.1038/icb.2010.52.View ArticlePubMedGoogle Scholar
- Cannas A, Naguleswaran A, Müller N, Eperon S, Gottstein B, Hemphill A: Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology. 2003, 126: 303-312. 10.1017/S0031182002002895.View ArticlePubMedGoogle Scholar
- Alaeddine F, Keller N, Leepin A, Hemphill A: Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol. 2005, 91: 657-665. 10.1645/GE-401R.View ArticlePubMedGoogle Scholar
- Debache K, Alaeddine F, Guionaud C, Monney T, Müller J, Strohbusch M, Leib SL, Grandgirard D, Hemphill A: Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol. 2009, 39: 1373-1384. 10.1016/j.ijpara.2009.04.006.View ArticlePubMedGoogle Scholar
- Aguado-Martínez A, Alvarez-García G, Fernández-García A, Risco-Castillo V, Marugán-Hernández V, Ortega-Mora LM: Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Vaccine. 2009, 27: 7331-7338. 10.1016/j.vaccine.2009.09.050.View ArticlePubMedGoogle Scholar
- Nishikawa Y, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H: Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene. Vaccine. 2001, 19: 1710-1716. 10.1016/S0264-410X(00)00407-2.View ArticlePubMedGoogle Scholar
- Ramammoorthy S, Sanakkayala N, Vemulapalli R, Jain N, Lindsay DS, Schurig GS: Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens. Int J Parasitol. 2007, 37: 1531-1538. 10.1016/j.ijpara.2007.04.021.View ArticleGoogle Scholar
- Ramammoorthy S, Lindsay DS, Schurig GS, Boyle SM, Duncan RB, Vemulapalli R, Sriranganathan N: Vaccination with γ-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum. J Eurkaryot Microbiol. 2006, 53: 151-156. 10.1111/j.1550-7408.2005.00083.x.View ArticleGoogle Scholar
- Bartley PM, Wright S, Chianini F, Buxton D, Innes EA: Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum. Parasitology. 2008, 135: 13-21.View ArticlePubMedGoogle Scholar
- Lundén A, Wright S, Allen JE, Buxton D: Immunisation of mice against neosporosis. Int J Parasitol. 2002, 32: 867-876. 10.1016/S0020-7519(02)00024-3.View ArticlePubMedGoogle Scholar
- Ribeiro DP, Freitas MMP, Cardoso MRD, Pajuaba ACAM, Silva NM, Mineo TWP, Silva JS, Mineo JR, Silva DAO: CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice. Vaccine. 2009, 27: 2570-2579. 10.1016/j.vaccine.2009.02.028.View ArticlePubMedGoogle Scholar
- Rojo-Montejo S, Collantes-Fernández E, Regidor-Cerrillo J, Rodríguez-Bertos A, Prenafeta A, Gomez-Bautista M, Ortega-Mora LM: Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice. Vet Parasitol. 2011, 175: 220-229. 10.1016/j.vetpar.2010.10.028.View ArticlePubMedGoogle Scholar
- Moore DP, Echaide I, Verna AE, Leunda MR, Cano A, Pereyra S, Zamorano PI, Odeón AC, Campero CM: Immune response to Neospora caninum native antigens formulated with immune stimulating complexes in calves. Vet Parasitol. 2011, 175: 245-251. 10.1016/j.vetpar.2010.10.020.View ArticlePubMedGoogle Scholar
- Peumans WJ, Van Damme EJ: Lectins as plant defense proteins. Plant Physiol. 1995, 109: 347-352. 10.1104/pp.109.2.347.PubMed CentralView ArticlePubMedGoogle Scholar
- Teixeira CR, Cavassani KA, Gomes RB, Teixeira MJ, Roque-Barreira MC, Cavada BS, Silva JS, Barral A, Barral-Neto M: Potential of KM+ lectin in immunization against Leishmania amazonensis infection. Vaccine. 2006, 24: 3001-3008. 10.1016/j.vaccine.2005.11.067.View ArticlePubMedGoogle Scholar
- Toledo KA, Schwartz C, Oliveira AF, Conrado MCAV, Bernardes ES, Fernandes LC, Roque-Barreira MC, Pereira-da-Silva G, Moreno AN: Neutrophil activation induced by ArtinM: release of inflammatory mediators and enhancement of effector functions. Immunol Lett. 2009, 123: 14-20. 10.1016/j.imlet.2009.01.009.View ArticlePubMedGoogle Scholar
- Cardoso MRD, Mota CM, Ribeiro DP, Santiago FM, Carvalho JV, Araujo EC, Silva NM, Mineo TWP, Roque-Barreira MC, Mineo JR, Silva DAO: ArtinM, a D-mannose-binding lectin from Artocarpus integrifolia, plays a potent adjuvant and immunostimulatory role in immunization against Neospora caninum. Vaccine. 2011, 29: 9183-9193. 10.1016/j.vaccine.2011.09.136.View ArticlePubMedGoogle Scholar
- Souza MA, Amancio-Pereira F, Barros-Cardoso CR, Gomes-Silva A, Silva EG, Andrade LR, Pena JDO, Lanza H, Afonso-Cardoso SR: Isolation and partial characterization of a D-galactose-binding lectin from the latex of Synadenium carinatum. Braz Arch Biol Technol. 2005, 48: 705-716.Google Scholar
- Afonso-Cardoso SR, Rodrigues FH, Gomes MAB, Silva AG, Rocha A, Guimarães AHB, Candeloro I, Favoreto S, Souza MA, Ferreira MS: Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice. Kor J Parasitol. 2007, 45: 255-266. 10.3347/kjp.2007.45.4.255.View ArticleGoogle Scholar
- Rogério AP, Barros-Cardoso CR, Fontanari C, Souza MA, Afonso-Cardoso SR, Silva EVG, Koyama NS, Basei FL, Soares EG, Calixto JB, Stowell SR, Dias-Baruffi M, Faccioli LH: Anti-asthmatic potential of a D-galactose-binding lectin from Synadenium carinatum latex. Glycobiology. 2007, 17: 795-804. 10.1093/glycob/cwm053.View ArticlePubMedGoogle Scholar
- Dubey JP, Carpenter JL, Speer CA, Topper MJ, Uggla A: Newly recognized fatal protozoan disease of dogs. J Am Vet Med Assoc. 1988, 192: 1269-1285.PubMedGoogle Scholar
- Silva DAO, Lobato J, Mineo TW, Mineo JR: Evaluation of serological tests for the diagnosis of Neospora caninum infection in dogs: optimization of cut off titers and inhibition studies of cross-reactivity with Toxoplasma gondii. Vet Parasitol. 2007, 143: 234-244. 10.1016/j.vetpar.2006.08.028.View ArticlePubMedGoogle Scholar
- Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 1985, 150: 76-85. 10.1016/0003-2697(85)90442-7.View ArticlePubMedGoogle Scholar
- Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999, 223: 77-92. 10.1016/S0022-1759(98)00204-X.View ArticlePubMedGoogle Scholar
- Bartley PM, Wright S, Sales J, Chianini F, Buxton D, Innes EA: Long-term passage of tachyzoites in tissue culture can attenuate virulence of Neospora caninum in vivo. Parasitology. 2006, 135: 421-432.View ArticleGoogle Scholar
- Vasta GR: Roles of galectins in infection. Nat Rev Microbiol. 2009, 7: 424-438. 10.1038/nrmicro2146.PubMed CentralView ArticlePubMedGoogle Scholar
- Panunto-Castelo A, Souza MA, Roque-Barreira MC, Silva JS: KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection. Glycobiology. 2001, 11: 1035-1042. 10.1093/glycob/11.12.1035.View ArticlePubMedGoogle Scholar
- Ellis J, Miller C, Quinn H, Ryce C, Reichel MP: Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine. 2008, 26: 5989-5996. 10.1016/j.vaccine.2008.08.043.View ArticlePubMedGoogle Scholar
- Nishikawa Y, Zhang H, Ikehara Y, Kojima N, Xuan X, Yokoyama N: Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice. Clin Vaccine Immunol. 2009, 16: 792-797. 10.1128/CVI.00032-09.PubMed CentralView ArticlePubMedGoogle Scholar
- Monney T, Rütti D, Schorer M, Debache K, Grandgirard D, Leib SL, Hemphill A: RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection. Vaccine. 2011, 29: 6967-6975. 10.1016/j.vaccine.2011.07.038.View ArticlePubMedGoogle Scholar
- Afonso-Cardoso SR, Silva CV, Ferreira MS, Souza MA: Effect of the Synadenium carinatum latex lectin (ScLL) on Leishmania (Leishmania) amazonensis infection in murine macrophages. Exp Parasitol. 2011, 128: 61-67. 10.1016/j.exppara.2011.02.006.View ArticlePubMedGoogle Scholar
- Debache K, Guionaud C, Alaeddine F, Hemphill A: Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites. Parasitology. 2010, 137: 229-240. 10.1017/S0031182009991259.View ArticlePubMedGoogle Scholar
- Debache K, Kropf C, Schütz CA, Harwood LJ, Käuper P, Monney T, Rossi N, Laue C, McCullough KC, Hemphill A: Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites. Parasite Immunol. 2011, 33: 81-94. 10.1111/j.1365-3024.2010.01255.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.